Synthesis and investigation of selective human carbonic anhydrase IX, XII inhibitors using coumarins bearing a sulfonamide or biotin moiety
- 21 October 2024
- journal article
- research article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 404, 111284
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Design and synthesis of sulfonamides incorporating a biotin moiety: Carbonic anhydrase inhibitory effects, antiproliferative activity and molecular modeling studiesBioorganic & Medicinal Chemistry, 2023
- The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugsCancer Letters, 2023
- 6‐Aminocoumarin oxime‐ether/sulfonamides as selective hCA IX and XII inhibitors: Synthesis, evaluation, and molecular dynamics studiesArchiv der Pharmazie, 2023
- Selective carbonic anhydrase IX and XII inhibitors based around a functionalized coumarin scaffoldDrug Development Research, 2023
- Chronic acidosis rewires cancer cell metabolism through PPARα signalingInternational Journal of Cancer, 2023
- Click chemistry‐based synthesis of new benzenesulfonamide derivatives bearing triazole ring as selective carbonic anhydrase II inhibitorsDrug Development Research, 2022
- Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of oneMedicinal Research Reviews, 2018
- Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XIIBioorganic & Medicinal Chemistry, 2016
- Synthesis of some new 1,3,5-trisubstituted pyrazolines bearing benzene sulfonamide as anticancer and anti-inflammatory agentsBioorganic & Medicinal Chemistry Letters, 2011
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004